United-Guardian, Inc.(UG)Earnings, Financials & Key Ratios

UG•NASDAQ

$6.71

$31M mkt cap·14.6× P/E·Price updated May 6, 2026

SectorConsumer Defensive IndustryHousehold Products Sub-IndustrySuppliers, Durables and Specialty Retailers

AboutUnited-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL NATURAL consisting of natural ingredients for cosmetic use; LUBRAJEL MARINE; LUBRASIL II SB, a special formulation of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base; LUBRAJEL II XD; B-122, a powdered lubricant that is used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; KLENSOFT, a surfactant, which is used in shampoos, shower gels, makeup removers, and other cosmetic formulations; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL LC and LUBRAJEL FA that are LUBRAJEL formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial product to treat infections in the urinary bladder, and localized infections in the peritoneum, as well as eye, ear, nose and throat, and sinuses. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and development primarily related to the development of cosmetic ingredients. It markets its products through marketing partners, distributors, and wholesalers. The company was founded in 1942 and is based in Hauppauge, New York.Show more

Revenue$11M-13.4%
EBITDA$2M-37.2%
Net Income$2M-35.2%
EPS (Diluted)0.46-35.2%
Gross Margin47.73%-10.0%
EBITDA Margin22.3%-27.4%
Operating Margin21.27%-28.9%
Net Margin19.97%-25.2%
ROE18.22%-34.8%
ROIC16.84%-59.5%

Technical→

UG Key Insights

United-Guardian, Inc. (UG) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Excellent 3Y average ROE of 23.7%
✓FCF machine: 18.1% free cash flow margin
✓Healthy 5Y average net margin of 24.8%

✗Weaknesses

✗Dividend payout exceeds 100% of earnings
✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

UG Price & Volume

United-Guardian, Inc. (UG) stock price & volume — 10-year historical chart

Loading chart...

UG Growth Metrics

United-Guardian, Inc. (UG) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-2.8%

5 Years-0.82%

3 Years-6.01%

TTM-13.43%

Profit CAGR

10 Years-7.53%

5 Years-8.62%

3 Years-6.42%

TTM-35.23%

EPS CAGR

10 Years-7.47%

5 Years-8.57%

3 Years-6.35%

TTM-35.21%

Return on Capital

10 Years37.2%

5 Years35.13%

3 Years26%

Last Year18.95%

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	Debt / Equity
IOSPInnospec Inc.Direct Competitor	1.92B	77.67	16.63	-3.65%	6.56%	8.23%	0.06
KRMDKORU Medical Systems, Inc.Direct Competitor	186.52M	4.01	-70.23	22.23%	-5.27%	-13.61%	0.21
LIQTLiqTech International, Inc.Direct Competitor	20.79M	2.16	-2.43	13.03%	-53.25%	-69.97%	1.17
CODACoda Octopus Group, Inc.Direct Competitor	134.35M	11.92	32.22	30.75%	14.78%	7.17%	0.01
CBTCabot CorporationProduct Competitor	4.3B	82.41	13.69	-7.04%	7.97%	16.75%	0.71
BCPCBalchem CorporationProduct Competitor	5.17B	161.38	33.97	8.75%	14.95%	12.38%	0.15
HWKNHawkins, Inc.Product Competitor	3.47B	167.11	41.47	6.01%	7.75%	15.88%	0.35
ASIXAdvanSix Inc.Product Competitor	834.75M	25.16	13.98	0.31%	3.24%	6.05%	0.47

Compare UG vs Peers

United-Guardian, Inc. (UG) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs IOSP

Most directly comparable listed peer for UG.

Scale Benchmark

vs ECL

Larger-name benchmark to compare UG against a more recognizable public peer.

Peer Set

Compare Top 5

vs IOSP, KRMD, LIQT, CODA

UG Income Statement

United-Guardian, Inc. (UG) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25
Sales/Revenue	12.97M	13.77M	13.6M	10.99M	13.93M	12.7M	10.89M	12.18M	10.55M
Revenue Growth %	20.33%	6.18%	-1.24%	-19.21%	26.79%	-8.84%	-14.28%	11.91%	-13.43%
Cost of Goods Sold	5.3M	5.67M	5.66M	4.87M	5.75M	6M	5.48M	5.72M	5.51M
COGS % of Revenue	40.88%	41.16%	41.6%	44.35%	41.26%	47.22%	50.34%	46.97%	52.27%
Gross Profit	7.67M▲ 0%	8.1M▲ 5.7%	7.94M▼ 2.0%	6.11M▼ 23.0%	8.18M▲ 33.8%	6.7M▼ 18.1%	5.41M▼ 19.3%	6.46M▲ 19.5%	5.03M▼ 22.1%
Gross Margin %	59.12%	58.84%	58.4%	55.65%	58.74%	52.78%	49.66%	53.03%	47.73%
Gross Profit Growth %	30.07%	5.68%	-1.98%	-23.02%	33.82%	-18.08%	-19.35%	19.51%	-22.1%
Operating Expenses	2.43M	2.52M	2.55M	2.48M	2.51M	2.66M	2.54M	2.81M	2.79M
OpEx % of Revenue	18.75%	18.32%	18.72%	22.55%	18.05%	20.99%	23.36%	23.1%	26.45%
Selling, General & Admin	1.79M	2.12M	0	0	0	0	0	0	0
SG&A % of Revenue	13.77%	15.42%	-	-	-	-	-	-	-
Research & Development	646.08K	399.52K	397.39K	451.21K	478.64K	490.77K	463.99K	456.78K	463.64K
R&D % of Revenue	4.98%	2.9%	2.92%	4.11%	3.44%	3.86%	4.26%	3.75%	4.4%
Other Operating Expenses	0	0	2.15M	2.03M	2.04M	2.17M	2.08M	2.36M	2.33M
Operating Income	5.24M▲ 0%	5.58M▲ 6.6%	5.4M▼ 3.3%	3.64M▼ 32.6%	5.67M▲ 55.9%	4.04M▼ 28.8%	2.86M▼ 29.1%	3.65M▲ 27.4%	2.24M▼ 38.5%
Operating Margin %	40.37%	40.52%	39.68%	33.1%	40.68%	31.79%	26.3%	29.94%	21.27%
Operating Income Growth %	54.46%	6.57%	-3.3%	-32.61%	55.85%	-28.76%	-29.08%	27.38%	-38.48%
EBITDA	5.44M	5.77M	5.57M	3.8M	5.81M	4.17M	2.97M	3.74M	2.35M
EBITDA Margin %	41.92%	41.92%	40.97%	34.6%	41.73%	32.86%	27.27%	30.72%	22.3%
EBITDA Growth %	52%	6.17%	-3.47%	-31.77%	52.92%	-28.22%	-28.85%	26.07%	-37.17%
D&A (Non-Cash Add-back)	200.68K	191.94K	175.81K	165.26K	145.98K	135.4K	105.68K	95.89K	108.2K
EBIT	5.24M	5.58M	5.4M	3.64M	5.67M	4.04M	2.86M	3.65M	2.24M
Net Interest Income	0	0	203.33K	226.25K	233.86K	-1.38M	306.65K	434.68K	365.31K
Interest Income	0	0	203.33K	226.25K	233.86K	236.69K	306.65K	434.68K	365.31K
Interest Expense	0	227.98K	-	0	0	1.62M	0	0	0
Other Income/Expense	315.17K	-113.99K	634.4K	524.83K	210.84K	-809.55K	387.75K	461.67K	399.67K
Pretax Income	5.55M▲ 0%	5.47M▼ 1.5%	6.03M▲ 10.3%	4.16M▼ 31.0%	5.88M▲ 41.3%	3.23M▼ 45.1%	3.25M▲ 0.7%	4.11M▲ 26.4%	2.64M▼ 35.7%
Pretax Margin %	42.8%	39.7%	44.34%	37.88%	42.2%	25.42%	29.86%	33.73%	25.06%
Income Tax	1.71M	1.11M	1.27M	856.02K	1.22M	658.17K	669.41K	857.58K	537.28K
Effective Tax Rate %	30.74%	20.37%	21.04%	20.57%	20.75%	20.39%	20.59%	20.87%	20.33%
Net Income	3.84M▲ 0%	4.35M▲ 13.2%	4.76M▲ 9.4%	3.3M▼ 30.6%	4.66M▲ 41.0%	2.57M▼ 44.8%	2.58M▲ 0.5%	3.25M▲ 25.9%	2.11M▼ 35.2%
Net Margin %	29.64%	31.61%	35.01%	30.08%	33.44%	20.23%	23.71%	26.69%	19.97%
Net Income Growth %	48.94%	13.22%	9.41%	-30.59%	40.96%	-44.84%	0.46%	25.94%	-35.23%
Net Income (Continuing)	3.84M	4.35M	4.76M	3.3M	4.66M	2.57M	2.58M	3.25M	2.11M
Discontinued Operations	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0
EPS (Diluted)	0.84▲ 0%	0.95▲ 13.1%	1.04▲ 9.5%	0.72▼ 30.8%	1.01▲ 40.3%	0.56▼ 44.6%	0.56▲ 0.0%	0.71▲ 26.8%	0.46▼ 35.2%
EPS Growth %	50%	13.1%	9.47%	-30.77%	40.28%	-44.55%	0%	26.79%	-35.21%
EPS (Basic)	0.84	0.95	1.04	0.72	1.01	0.56	0.56	0.71	0.46
Diluted Shares Outstanding	4.59M	4.58M	4.59M	4.59M	4.59M	4.59M	4.59M	4.59M	4.59M
Basic Shares Outstanding	4.59M	4.58M	4.59M	4.59M	4.59M	4.59M	4.59M	4.59M	4.59M
Dividend Payout Ratio	169.27%	110.66%	106.05%	108.39%	111.41%	121.56%	17.8%	84.79%	131.39%

UG Balance Sheet

United-Guardian, Inc. (UG) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25
Total Current Assets	11.85M	11.69M	11.57M	11.25M	11.58M	9.97M	12.25M	12.67M	12.2M
Cash & Short-Term Investments	8.45M	8.17M	7.92M	8.18M	8.17M	6.48M	9.09M	9.4M	8.57M
Cash Only	724.72K	550.13K	1.05M	591.44K	531.21K	830.45K	8.24M	1.88M	1.25M
Short-Term Investments	7.72M	7.62M	6.87M	7.59M	7.64M	5.65M	851.32K	7.52M	7.32M
Accounts Receivable	1.91M	1.67M	2.1M	1.39M	1.81M	1.43M	1.57M	1.43M	1.59M
Days Sales Outstanding	53.63	44.34	56.32	46.1	47.52	41.03	52.54	42.8	54.93
Inventory	1.34M	1.48M	1.22M	1.42M	1.41M	1.67M	1.22M	1.45M	1.51M
Days Inventory Outstanding	92.3	95.46	78.54	106.06	89.59	101.78	81.5	92.63	99.83
Other Current Assets	157.96K	159.36K	170.47K	161.21K	0	201.85K	191.71K	207.8K	207.84K
Total Non-Current Assets	1M	857.57K	795.53K	673.66K	658.86K	669.71K	670.13K	1.13M	1.26M
Property, Plant & Equipment	942.89K	827.92K	780.71K	673.66K	658.86K	559.16K	619.2K	956.39K	907.18K
Fixed Asset Turnover	13.75x	16.63x	17.42x	16.31x	21.14x	22.71x	17.58x	12.74x	11.62x
Goodwill	0	0	0	0	0	0	0	0	0
Intangible Assets	0	0	14.82K	0	0	0	0	0	0
Long-Term Investments	0	0	-401.68K	0	0	0	0	0	0
Other Non-Current Assets	-111.7K	-223.94K	14.82K	-151.68K	-83.22K	0	0	0	0
Total Assets	12.85M▲ 0%	12.54M▼ 2.4%	12.36M▼ 1.4%	11.92M▼ 3.6%	12.24M▲ 2.7%	10.64M▼ 13.1%	12.92M▲ 21.5%	13.8M▲ 6.8%	13.46M▼ 2.4%
Asset Turnover	1.01x	1.10x	1.10x	0.92x	1.14x	1.19x	0.84x	0.88x	0.78x
Asset Growth %	-14.99%	-2.4%	-1.45%	-3.58%	2.7%	-13.09%	21.45%	6.77%	-2.42%
Total Current Liabilities	1.42M	1.37M	1.34M	1.41M	2.34M	1.37M	1.53M	1.91M	1.67M
Accounts Payable	354.29K	186.8K	71.39K	31.8K	410.89K	30.41K	134.45K	425K	480.79K
Days Payables Outstanding	24.39	12.03	4.61	2.38	26.09	1.85	8.96	27.11	31.83
Short-Term Debt	0	0	0	0	0	0	0	0	0
Deferred Revenue (Current)	0	0	0	0	190.16K	0	15.5K	0	12.18K
Other Current Liabilities	314.54K	299.25K	373.94K	321.74K	898.4K	638.98K	543.85K	681.73K	1.16M
Current Ratio	8.33x	8.55x	8.61x	7.95x	4.95x	7.26x	7.99x	6.62x	7.31x
Quick Ratio	7.39x	7.47x	7.71x	6.95x	4.35x	6.04x	7.19x	5.86x	6.41x
Cash Conversion Cycle	121.53	127.76	130.25	149.78	111.01	140.96	125.08	108.32	122.92
Total Non-Current Liabilities	33.85K	253.58K	386.86K	151.68K	83.22K	0	0	0	207.25K
Long-Term Debt	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	0	0	0	0	0	0	0	0	0
Deferred Tax Liabilities	33.85K	253.58K	386.86K	151.68K	83.22K	0	0	0	207.25K
Other Non-Current Liabilities	0	0	0	0	0	0	0	0	0
Total Liabilities	1.46M	1.62M	1.73M	1.57M	2.42M	1.37M	1.53M	1.91M	2.23M
Total Debt	0	0	0	0	0	0	0	0	0
Net Debt	-724.72K	-550.13K	-1.05M	-591.44K	-531.21K	-830.45K	-8.24M	-1.88M	-1.25M
Debt / Equity	-	-	-	-	-	-	-	-	-
Debt / EBITDA	-	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-0.13x	-0.10x	-0.19x	-0.16x	-0.09x	-0.20x	-2.78x	-0.50x	-0.53x
Interest Coverage	-	24.48x	-	-	-	2.49x	-	-	-
Total Equity	11.4M▲ 0%	10.92M▼ 4.1%	10.63M▼ 2.7%	10.35M▼ 2.6%	9.82M▼ 5.1%	9.27M▼ 5.6%	11.39M▲ 22.9%	11.88M▲ 4.3%	11.23M▼ 5.5%
Equity Growth %	-17.54%	-4.14%	-2.67%	-2.62%	-5.15%	-5.65%	22.9%	4.34%	-5.48%
Book Value per Share	2.48	2.38	2.31	2.25	2.14	2.02	2.48	2.59	2.44
Total Shareholders' Equity	11.4M	10.92M	10.63M	10.35M	9.82M	9.27M	11.39M	11.88M	11.23M
Common Stock	459.43K	459.43K	459.43K	459.43K	459.43K	459.43K	459.43K	459.43K	459.43K
Retained Earnings	10.47M	10.47M	10.17M	9.89M	9.36M	8.81M	10.93M	11.42M	10.77M
Treasury Stock	0	0	0	0	0	0	0	0	0
Accumulated OCI	466.02K	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0

UG Cash Flow Statement

United-Guardian, Inc. (UG) cash flow — operating, investing & free cash flow history

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25
Cash from Operations	3.99M	4.95M	4.48M	3.59M	5.31M	2.53M	3.14M	3.47M	1.97M
Operating CF Margin %	30.79%	35.95%	32.91%	32.72%	38.14%	19.89%	28.89%	28.45%	18.65%
Operating CF Growth %	74.3%	24%	-9.58%	-19.7%	47.83%	-52.47%	24.53%	10.23%	-43.26%
Net Income	3.84M	4.35M	4.76M	3.3M	4.66M	2.57M	2.58M	3.25M	2.11M
Depreciation & Amortization	200.68K	191.94K	175.81K	165.26K	145.98K	135.4K	105.68K	95.89K	108.2K
Stock-Based Compensation	0	0	0	0	0	0	0	0	0
Deferred Taxes	-31.76K	219.73K	133.27K	-235.17K	-68.46K	-193.77K	59.61K	-124.47K	382.64K
Other Non-Cash Items	-29.02K	341.65K	-411.79K	-305.75K	14.45K	1.08M	-111.49K	-43.53K	-32.32K
Working Capital Changes	8.1K	-155.24K	-182.89K	664.92K	562.77K	-1.06M	509.3K	287.49K	-597.44K
Change in Receivables	-311.69K	237.17K	-430.13K	717.87K	-431.88K	385.96K	-135.87K	140.71K	-161.26K
Change in Inventory	-84.71K	-141.63K	249.87K	-198.5K	4.98K	-290.22K	465.51K	-214.28K	-54.98K
Change in Payables	271.46K	-167.49K	-115.41K	-39.59K	379.09K	-380.48K	104.03K	290.55K	55.79K
Cash from Investing	2.82M	-308.76K	1.07M	-468.68K	-183.47K	897.56K	4.73M	-7.08M	175.34K
Capital Expenditures	-38.15K	-74.99K	-113.77K	-43.4K	-116.38K	-75.18K	-165.72K	-433.08K	-58.99K
CapEx % of Revenue	0.29%	0.54%	0.84%	0.4%	0.84%	0.59%	1.52%	3.56%	0.56%
Acquisitions	4.85K	70.79K	113.77K	43.4K	116.38K	37.04K	0	0	0
Investments	-	-	-	-	-	-	-	-	-
Other Investing	-4.85K	-70.79K	-113.77K	-43.4K	-116.38K	0	10K	0	0
Cash from Financing	-6.51M	-4.82M	-5.05M	-3.58M	-5.19M	-3.12M	-459.39K	-2.76M	-2.77M
Debt Issued (Net)	0	0	0	0	0	0	0	0	0
Equity Issued (Net)	0	0	0	0	0	0	0	0	0
Dividends Paid	-6.51M	-4.82M	-5.05M	-3.58M	-5.19M	-3.12M	-459.39K	-2.76M	-2.77M
Share Repurchases	0	0	0	0	0	0	0	0	0
Other Financing	0	0	0	0	0	0	0	0	0
Net Change in Cash	300.42K▲ 0%	-174.59K▼ 158.1%	498.18K▲ 385.3%	-456.87K▼ 191.7%	-60.23K▲ 86.8%	299.24K▲ 596.8%	7.41M▲ 2377.2%	-6.37M▼ 185.9%	-624.56K▲ 90.2%
Free Cash Flow	3.95M▲ 0%	4.88M▲ 23.3%	4.36M▼ 10.5%	3.55M▼ 18.6%	5.2M▲ 46.4%	2.45M▼ 52.9%	2.98M▲ 21.6%	3.03M▲ 1.8%	1.91M▼ 37.1%
FCF Margin %	30.49%	35.41%	32.08%	32.32%	37.31%	19.29%	27.37%	24.9%	18.09%
FCF Growth %	86.19%	23.3%	-10.52%	-18.6%	46.36%	-52.86%	21.58%	1.83%	-37.1%
FCF per Share	0.86	1.06	0.95	0.77	1.13	0.53	0.65	0.66	0.42
FCF Conversion (FCF/Net Income)	1.04x	1.14x	0.94x	1.09x	1.14x	0.98x	1.22x	1.07x	0.93x
Interest Paid	0	0	0	0	0	0	0	0	0
Taxes Paid	1.6M	1.15M	1.1M	1.02M	1.1M	1.13M	600K	1.05M	0

UG Key Ratios

United-Guardian, Inc. (UG) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	18.2%	30.49%	39%	44.18%	31.5%	46.18%	26.92%	24.99%	27.94%	18.22%
Return on Invested Capital (ROIC)	18.93%	32.63%	39.77%	40.55%	28.19%	44.62%	34.16%	37.08%	41.59%	16.84%
Gross Margin	54.69%	59.12%	58.84%	58.4%	55.65%	58.74%	52.78%	49.66%	53.03%	47.73%
Net Margin	23.95%	29.64%	31.61%	35.01%	30.08%	33.44%	20.23%	23.71%	26.69%	19.97%
Interest Coverage	-	-	24.48x	-	-	-	2.49x	-	-	-
FCF Conversion	0.89x	1.04x	1.14x	0.94x	1.09x	1.14x	0.98x	1.22x	1.07x	0.93x
Revenue Growth	-23.06%	20.33%	6.18%	-1.24%	-19.21%	26.79%	-8.84%	-14.28%	11.91%	-13.43%

UG SEC Filings & Documents

United-Guardian, Inc. (UG) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

Mar 27, 2026·SEC

Material company update

Jan 29, 2026·SEC

Material company update

Nov 6, 2025·SEC

10-K Annual Reports

FY 2026

Mar 27, 2026·SEC

FY 2025

Mar 21, 2025·SEC

FY 2024

Mar 22, 2024·SEC

10-Q Quarterly Reports

FY 2025

Nov 6, 2025·SEC

FY 2025

Aug 8, 2025·SEC

FY 2025

May 13, 2025·SEC

UG Frequently Asked Questions

United-Guardian, Inc. (UG) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

United-Guardian, Inc. (UG) reported $10.5M in revenue for fiscal year 2025. This represents a 32% increase from $8.0M in 1996.

United-Guardian, Inc. (UG) saw revenue decline by 13.4% over the past year.

Yes, United-Guardian, Inc. (UG) is profitable, generating $2.1M in net income for fiscal year 2025 (20.0% net margin).

Dividend & Returns

Yes, United-Guardian, Inc. (UG) pays a dividend with a yield of 8.97%. This makes it attractive for income-focused investors.

United-Guardian, Inc. (UG) has a return on equity (ROE) of 18.2%. This is reasonable for most industries.

United-Guardian, Inc. (UG) generated $1.9M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More UG

United-Guardian, Inc. (UG) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

United-Guardian, Inc.(UG)Earnings, Financials & Key Ratios

UG Key Insights

✓Strengths

✗Weaknesses

UG Price & Volume

UG Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

UG Peer Comparison

Compare UG vs Peers

vs IOSP

vs ECL

Compare Top 5

UG Income Statement

UG Balance Sheet

UG Cash Flow Statement

UG Key Ratios

UG SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

UG Frequently Asked Questions

Explore More UG

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation